ELAB — PMGC Holdings Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1840563 ·
Last close
$6.52
Market Cap
$5.28M
52W High
$19.70
52W Low
$5.40
ADV30
82,720
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 681,994 | 230,474 | -3,320,057 | -4,967,259 | 26,033,318 | 14,354,374 | 13,426,865 |
| Dec 2025 | 304,136 | 107,284 | -2,410,864 | -2,982,683 | 12,868,473 | 5,402,333 | 5,031,111 |
| Sep 2025 | 285,948 | 78,030 | -2,194,727 | -2,594,320 | 14,938,018 | 7,700,562 | 6,447,363 |
| Jun 2025 | 0 | — | -1,014,401 | -562,355 | 9,375,476 | 5,682,628 | 326,301 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-7,566,060
Investing CF
$-5,033,444
Financing CF
$21,586,459
CapEx
$-1,105,342
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$-414.99
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-25,984,699
Inventory
$253,558
Receivables
$542,715
ST Investments
$733,405
EBIT TTM
$-10,434,391
Pretax Income TTM
$-11,155,717
Interest Exp TTM
$721,326
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$2,578,688
EBITDA
$-11,544,472
Free Cash Flow
$-4,133,820
Enterprise Value
$666,862
Total Cash
$18,963,356
Total Debt
$14,237,784
Shares Out
809,579
Trailing EPS
$-1830.96
Book Value
$27.20
ROE
-105.2%
ROA
-33.0%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 590,084 | -6,821,330 | -7,747,813 | 12,868,473 | 5,031,111 | — | -5,933,881 |
| Dec 2024 | 0 | -3,657,720 | -6,245,737 | 8,993,165 | 2,333,601 | — | -5,486,980 |
| Dec 2023 | 0 | -1,134,828 | -4,301,517 | 5,189,918 | 1,362,842 | — | -4,556,811 |
| Dec 2022 | 766,277 | -1,788,292 | -1,800,268 | 1,892,183 | 760,873 | — | -1,585,876 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| INBP | INTEGRATED BIOPHARMA INC | $5.19M | $0.17 | — |
| ADXN | Addex Therapeutics Ltd. | $5.13M | $4.05 | — |
| KAPA | Kairos Pharma, LTD. | $5.50M | $0.23 | — |
| HEPA | Hepion Pharmaceuticals, Inc. | $5.50M | $0.06 | — |
| LABT | Lakewood-Amedex Biotherapeutics Inc. | $5.05M | $2.13 | — |
News headlines (Yahoo Finance, 1h cache)
NorthStrive Biosciences Announces The Filing of Two U.S. Patent Applications Targeting Microgravity-Induced Muscle Loss During Long-Duration Spaceflight
2026-08-21 13:30 · Yahoo
PMGC Holdings Inc. Announces Anticipated Reverse Stock Split
2026-08-19 15:45 · Yahoo
PMGC Holdings Inc. [NASDAQ: ELAB] Reports Q2 2026 Results and Files Form 10-Q; Total Assets Reach $36.6 Million, Up 184% from Year-End 2025 and 290% Year-over-Year, as Quarterly Revenue Nearly Doubles
2026-08-14 13:31 · Yahoo
PMGC Holdings Confirms Compliance with Nasdaq’s New $5 Million Market Value of Listed Securities Requirement
2026-07-29 19:54 · Yahoo
PMGC Holdings Inc. Announces Strategic Investment in Precision Aerospace & Defense Group and Long-Term Aerospace and Defense Manufacturing Agreement Through A&B Aerospace Inc.
2026-07-28 11:30 · Yahoo
NorthStrive Defense Tech Executes Definitive Exclusive License Agreement with Florida State University Research Foundation for Multi-Domain Drone Payload Technology Across Defense, Aerospace and Marit
2026-07-13 11:30 · Yahoo
PMGC Holdings Advances EL-22 FACS Analysis to Support Manufacturing Comparability
2026-07-10 15:00 · Yahoo
PMGC Holdings Inc. Announces Merger of AGA Precision Systems into A&B Aerospace
2026-07-06 11:30 · Yahoo
GB Capital Ltd. Co-Advises on the Acquisition of A&B Aerospace Inc.
2026-05-18 13:00 · Yahoo
PMGC Holdings Inc. [NASDAQ: ELAB] Reports Q1 2026 Results and Files Form 10-Q; Total Assets Reach Over $26.0 Million, Up 102% from Year-End 2025 and 193% Year-over-Year
2026-05-15 11:02 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.